Biomarin Pharmaceuticals (NQ: BMRN )

76.08 USD UNCHANGED

Streaming Delayed Price Updated: 7:09 PM EDT, Sep 30, 2020 Add to My Watchlist

Price and Volume

Volume	0
Open	76.08
Bid (Size)	75.05 (1)
Ask (Size)	77.98 (1)
Prev. Close	76.08
Today's Range	76.08 - 76.08
52wk Range	62.88 - 131.94
Shares Outstanding	176,713,314
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VXRT, GLNG and BMRN

September 30, 2020

BioMarin to Participate in Upcoming Virtual Investor Conference

September 29, 2020

- Morningstar's Management Behind the Moat Conference on September 30 at 1:00pm ET

Performance

YTD	-9.47%	-9.47%
1 Month	-2.50%	-2.50%
3 Month	-39.54%	-39.54%
6 Month	-8.98%	-8.98%
1 Year	+17.48%	+17.48%

More News

Portnoy Law: Lawsuit Filed On Behalf of BioMarin Pharmaceutical, Inc. Investors

September 30, 2020

BIOMARIN ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against BioMarin Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

September 29, 2020

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of BioMarin Pharmaceuticals Inc. (BMRN) on Behalf of Investors

September 30, 2020

BMRN INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages BioMarin Pharmaceutical (BMRN) Investors to Contact Its Attorneys, Securities Fraud Class Action Filed

September 29, 2020

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages BioMarin Pharmaceutical (BMRN) Investors to Contact Its Attorneys, Securities Fraud Class Action Filed

September 28, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioMarin Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadline – BMRN

September 28, 2020

BioMarin, Pioneer in Phenylketonuria (PKU) and Gene Therapy, Doses First Participant in Global PHEARLESS Phase 1/2 Study of BMN 307 Gene Therapy

September 24, 2020

SHAREHOLDER ALERT: BioMarin Pharmaceutical, Inc. Sued for Violations of the Federal Securities Laws; Investors Who Lost Money Should Contact Block & Leviton LLP

September 28, 2020

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against BioMarin Pharmaceutical Inc. and Encourages Investors with Losses in Excess of $100,000 to Conta

September 29, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.